Abstract 1236: FOLFIRINOX represents the preferred therapeutic option for patients with pancreatic acinar cell carcinoma: A multi-center study.
Year: 2026
Type: conference-abstract
Source: Cancer Research
Author: Guoliang Qiao
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7148798902
Cites:
Cited by:
Related to: